-
1
-
-
33846817134
-
Impact of and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: a randomised, double-blind, placebo-controlled study
-
Malhotra-Kumar S, Lammens C, Coenen S et al. Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007; 369: 482-90.
-
(2007)
Lancet
, vol.369
, pp. 482-490
-
-
Malhotra-Kumar, S.1
Lammens, C.2
Coenen, S.3
-
2
-
-
77953917693
-
Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis
-
Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
-
(2010)
BMJ
, vol.340
-
-
Costelloe, C.1
Metcalfe, C.2
Lovering, A.3
-
3
-
-
13844254907
-
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
-
Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
-
(2005)
Lancet
, vol.365
, pp. 579-587
-
-
Goossens, H.1
Ferech, M.2
Vander Stichele, R.3
-
4
-
-
72149120292
-
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries
-
Huttner B, Goossens H, Verheij T et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010; 10: 17-31.
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 17-31
-
-
Huttner, B.1
Goossens, H.2
Verheij, T.3
-
5
-
-
82055185445
-
European Surveillance of Antimicrobial Consumption: outpatient antibiotic use in Europe (1997-2009)
-
Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption: outpatient antibiotic use in Europe (1997- 2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi3-12.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Adriaenssens, N.1
Coenen, S.2
Versporten, A.3
-
6
-
-
82055196785
-
European Surveillance of Antimicrobial Consumption: outpatient penicillin use in Europe (1997-2009)
-
Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption: outpatient penicillin use in Europe (1997- 2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi13-23.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Versporten, A.1
Coenen, S.2
Adriaenssens, N.3
-
7
-
-
82055189979
-
European Surveillance of Antimicrobial Consumption: outpatient cephalosporin use in Europe (1997-2009)
-
Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption: outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi25-35.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Versporten, A.1
Coenen, S.2
Adriaenssens, N.3
-
8
-
-
82055196786
-
European Surveillance of Antimicrobial Consumption: outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)
-
Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption: outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi37-45.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Adriaenssens, N.1
Coenen, S.2
Versporten, A.3
-
9
-
-
82055183949
-
European Surveillance of Antimicrobial Consumption: outpatient quinolone use in Europe (1997-2009)
-
Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption: outpatient quinolone use in Europe (1997- 2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi47-56.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL 6
-
-
Adriaenssens, N.1
Coenen, S.2
Versporten, A.3
-
10
-
-
82055196779
-
European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009)
-
Coenen S, Adriaenssens N, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother 2011;66 Suppl 6: vi57-70.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Coenen, S.1
Adriaenssens, N.2
Versporten, A.3
-
13
-
-
0032416717
-
Likelihood ratio testing of variance components in the linear mixed-effects model using restricted maximum likelihood
-
Morrell H. Likelihood ratio testing of variance components in the linear mixed-effects model using restricted maximum likelihood. Biometrics 1998; 54: 1560-8.
-
(1998)
Biometrics
, vol.54
, pp. 1560-1568
-
-
Morrell, H.1
-
14
-
-
82055183945
-
Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis
-
Faes C, Molenberghs G, Hens N et al. Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis. J Antimicrob Chemother 2011; 66 Suppl 6: vi89-94.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 6
-
-
Faes, C.1
Molenberghs, G.2
Hens, N.3
-
15
-
-
84858448628
-
-
WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment. Oslo, (26 October 2011, date last accessed)
-
WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment 2011. Oslo. www.whocc.no/ filearchive/publications/2011guidelines.pdf (26 October 2011, date last accessed).
-
(2011)
-
-
-
17
-
-
57049125633
-
The first European Antibiotic Awareness Day after a decade of improving outpatient antibiotic use in Belgium
-
Coenen S, Costers M, De Corte S et al. The first European Antibiotic Awareness Day after a decade of improving outpatient antibiotic use in Belgium. Acta Clin Belg 2008; 63: 296-300.
-
(2008)
Acta Clin Belg
, vol.63
, pp. 296-300
-
-
Coenen, S.1
Costers, M.2
De Corte, S.3
-
18
-
-
60549097968
-
Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC)
-
Goossens H, Coenen S, Costers M et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill 2008; 13: pii=19036.
-
(2008)
Euro Surveill
, vol.13
-
-
Goossens, H.1
Coenen, S.2
Costers, M.3
-
19
-
-
67650305509
-
Significant reduction of antibiotic use in the community after a nationwide campaign in France 2002-2007
-
Sabuncu E, David J, Bernè de-Bauduin C et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009; 6: e1000084.
-
(2009)
PLoS Med
, vol.6
-
-
Sabuncu, E.1
David, J.2
Bernè de-Bauduin, C.3
-
20
-
-
70349250447
-
European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries
-
Earnshaw S, Monnet DL, Duncan B et al. European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill 2009; 14: pii=19280.
-
(2009)
Euro Surveill
, vol.14
-
-
Earnshaw, S.1
Monnet, D.L.2
Duncan, B.3
|